Keyword : pembrolizumab
Pembrolizumab is first-line treatment for patients with advanced non-small cell lung cancer in both mono and combination regimens
T. 10, № 1-2 (37-38) / Review: 4
T. 10, № 1-2 (37-38) / Review: 4
Immunotherapy of Hodgkin’s lymphoma: a new treatment strategy
Author:Kryachok I.A. Т. 8, № 2 (30) 2018 / Review: 1
Author:Kryachok I.A. Т. 8, № 2 (30) 2018 / Review: 1
A clinical case of treating of a patient with melanoma using checkpoint inhibitor pembolizumab (anti-PD-1 monoclonal antibody)Author:Kosinova V.G. №4(28) 2017 / Review: 1